Company Introduction

A firm that secures competitiveness through continuous development of
materials and the nurturing of bio specialists

History

2021
06

Obtained overseas export license for ‘Regenin-Filler’

05

Selected as “National Representative 1000 of Innovative Companies” promoted by the government

04

Completed preclinical trials for ‘Regenin-Filler’

04

Changed company name from H&B9 Co., Ltd. -> Nine Biopharm Co., Ltd.

2020
Nov

Awarded commendation from the Minister of Trade, Industry and Energy

Jul

Selected as ‘Bio Health Investment Infrastructure linked R&D Project’ from the Ministry of Health and Welfare

Jun

Dash in preclinical trials for ‘Regenin Filler’

Apr

Designated as a Star Company for global IP (intellectual property) by Chungcheongbuk-do Province

Apr

Attracted public funds from Korea Technology Finance Corporation

Apr

Certified as a venture company

Mar

Attracted investment from series A institutions

2019
Nov

Received AABI (Asian Association of Business Incubation) Torch-bearing Industry Award

Sep

Certified as Korean company with “Excellent Service Quality”

Jul

Selected as a Promising SME for Exports

Apr

Obtained ISO22716 Certification

Mar

Expanded research institutes (recruited directors of research institutes)

Feb

Registered company’s factory

2018
Dec

Obtained certification for being a family-friendly company
Received Cosmetic Company Award from Chungcheongbuk-do Province

Oct

Obtained Innobiz Certification for technological innovation

Oct

Obtained ISO9001 Certification
Received Main Prize, “SME Technology and Management Grand Prize”

Jul

Received Mainbiz Certification for managerial innovation

2017
Oct

Certified research institute affiliated with the corporation

Jul

Acquired Overseas Business Department

2015
Nov

Mr. JaeDuck Ryoo be installed as CEO

Aug

Installed research responsible department

Mar

Established HnB9